Clinical Trial Update: Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating nimotuzumab combined with radiotherapy for esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Biotech Pharmaceutical Co., Ltd. | Conditions: Esophageal | Phase 2 | Status: COMPLETED